Abstract:SESSION TITLE: Critical Care: ARDS/ALI SESSION TYPE: Original Investigation Poster PRESENTED ON: Saturday, April 16, 2016 at 11:45 AM - 12:45 PM PURPOSE: p38MAPK, a mitogen-activated protein kinase, plays a negative regulating role in the pathogenesis of acute respiratory distress syndrome (ARDS) induced by lipopolysaccharide (LPS). A p38MAPK inhibitor has previously been shown to alleviate inflammatory reaction. We recently proposed that the balance of T helper17 (Th17) and Treg cells regulated in this inflammatory conditions. In the present study, we investigated in vivo the effect of Th17/Treg balance on p38MAPK inhibitor relieved mild ARDS induced by LPS. METHODS: KM mice received SB203580 (0.5 and 5 mg/kg) intraperitoneally 1 h prior to the intratracheal instillation of lipopolysaccharide (LPS) challenge. All mice were killed on 12h respectively. Transcript expression of FOXP3 and RORrt was detected by real-time polymerase chain reaction; IL-6, IL-10, IL-17, IL-23, and transforming growth factor (TGF-b) in Lung tissue and IL-6, TNF-a in serum were measured by enzyme-linked immunosorbent assay. The Th17 and Treg subset distribution in Lung bronchial lymph nodes was determined by flow cytometry. We also investigated histopathological conditions in Lung tissue. RESULTS: In a LPS-induced ARDS mouse model, we found that the IL-6 and TNF-α protein concentration in the serum were lower in pretreatmenting with SB203580 groups and the production of inflammatory cytokines associate with Th17, including interleukin-17 (IL-17), IL-23, RORrt, and TGF-β was inhibited, and the production of cytokines associate with Treg, such as IL-10 and FOXP3 in Lung tissue was increased. In addition, histopathological examination indicates that SB203580 significantly attenuated tissue injury of the lungs in LPS-induced ALI. Furthermore, SB203580 also inhibited the production of Th17 cells and improved the production of Tregs in Lung bronchial lymph nodes. And the changes of cytokines had concentration dependence with SB203580 CONCLUSIONS: These results suggest that p38MAPK plays a protective effect in a LPS-induced ARDS mice model via regulating Th17/Treg balance. CLINICAL IMPLICATIONS: Our results further clarified the pathogenic mechanism of acute respiratory distress syndrome (ARDS) induced by lipopolysaccharide (LPS), and provided a novel basis for clinical treatment of ARDS DISCLOSURE: Jingjing Feng: University grant monies: Natural Science Foundation of Minhang District of Shanghai of China (No. 2010MHZ018), University grant monies: Young Scholars foundation of Shanghai Municipal Health Bureau (No. 2010Y036) Jindong Shi: University grant monies: Natural Science Foundation of Minhang District of Shanghai of China (No. 2010MHZ018), University grant monies: Young Scholars foundation of Shanghai Municipal Health Bureau (No. 2010Y036) Shanqun Li: University grant monies: Natural Science Foundation of Minhang District of Shanghai of China (No. 2010MHZ018), University grant monies: Young Scholars foundation of Shanghai Municipal Health Bureau (No. 2010Y036) Zhijun Jie: University grant monies: Natural Science Foundation of Minhang District of Shanghai of China (No. 2010MHZ018), University grant monies: Young Scholars foundation of Shanghai Municipal Health Bureau (No. 2010Y036) No Product/Research Disclosure Information

The P38 MAPK Inhibitor JLU1124 Inhibits the Inflammatory Response Induced by Lipopolysaccharide Through the MAPK-NF-κB Pathway in RAW264.7 Macrophages.

The p38 MAPK inhibitor SB203580 differentially modulates LPS-induced interleukin 6 expression in macrophages.

JNK‑IN‑8 Treatment Alleviates Lipopolysaccharide‑induced Acute Lung Injury Via Suppression of Inflammation and Oxidative Stress Regulated by JNK/NF‑κB Signaling.

Mollugin Inhibits the Inflammatory Response in Lipopolysaccharide-Stimulated RAW264.7 Macrophages by Blocking the Janus Kinase-Signal Transducers and Activators of Transcription Signaling Pathway

Feedback Control of MKP-1 Expression by P38

Lipoxin A 4 Inhibits NF-κB Activation and Cell Cycle Progression in RAW264.7 Cells

A Novel Chromone Derivative With Anti-Inflammatory Property Via Inhibition Of Ros-Dependent Activation Of Traf6-Ask1-P38 Pathway

Cell-free supernatant of Lactococcus lactis IDCC 2301 exerts anti-inflammatory effects in LPS-induced macrophages via NF-κB and MAPK signaling pathways

Macrophage deletion of p38alpha partially impairs lipopolysaccharide-induced cellular activation.

The Anti-inflammatory Effect of the Benzoxazole Compound K310 on the LPS-stimulated RAW264.7 Macrophages

7B, a Novel Naphthalimide Derivative, Exhibited Anti-Inflammatory Effects Via Targeted-Inhibiting TAK1 Following Down-Regulation of ERK1/2- and P38 MAPK-mediated Activation of NF-κB in LPS-stimulated RAW264.7 Macrophages

Effect of LX A4 and BML-111 on TLR4/NF-κB Signaling Pathway in Macrophage

Inhibition of Inflammation by a P38 MAP Kinase Targeted Cell Permeable Peptide

Pomegranate Peel Polyphenols Inhibits Inflammation in LPS-induced RAW264.7 Macrophages Via the Suppression of TLR4/NF-κB Pathway Activation.

The Anti-Inflammatory Effect of Ent-Kaur-15-en-17-al-18-oic Acid on Lipopolysaccharide-Stimulated RAW264.7 Cells Associated with NF-κB and P38/MAPK Pathways.

Role of P38 MAPK in Lipopolysaccharide-Induced Inos Expression by Endothelial Cells

Role of p38 MAPK in ICAM-1 expression of vascular endothelial cells induced by lipopolysaccharide.

SB203580 Protects Against Inflammatory Response and Lung Injury in a Mouse Model of Lipopolysaccharide‑induced Acute Lung Injury.

P38mapk Inhibitor Ameliorates Lipopolysaccharide-Induced Mild Acute Respiratory Distress Syndrome Through Regulating the Balance of Treg Cells and Th17 Cells

Inhibitory effect of 5-Pyridin-2-ylmethylene-6,7-dihydro-5H-benzo[b]thiophen-4-one (PT-2-318) on NF-kB and AP-1 activation in macrophages (CAM5P.235)

NZ Suppresses TLR4/NF-κB Signalings and NLRP3 Inflammasome Activation in LPS-induced RAW264.7 Macrophages